Evaluation of Rapid Onset of Action of ICS/LABA Combination Therapies on Respiratory Function in Asthma Patients: A Single-Center, Open-Label, Randomized, Crossover Trial
Abstract Introduction Products based on inhaled corticosteroid (ICS)/long-acting β2 agonist (LABA) combinations may provide different clinical benefits. This study was conducted to compare the rapid effects of three such combination products: formoterol/fluticasone (FFC) aerosol (pMDI), formoterol/b...
Main Authors: | Hiroyuki Ohbayashi, Sahori Kudo, Mitsue Ariga |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2018-09-01
|
Series: | Pulmonary Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1007/s41030-018-0062-x |
Similar Items
-
LABA/LAMA combinations versus LAMA monotherapy or LABA/ICS in COPD: a systematic review and meta-analysis
by: Rodrigo GJ, et al.
Published: (2017-03-01) -
The Global Initiative for Asthma 2019 recommendation for mild asthma – A critique
by: Elvis M. Irusen
Published: (2020-03-01) -
Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review
by: Saeed Noibi, et al.
Published: (2020-08-01) -
Combined fluticasone furoate/vilanterol reduces decline in lung function following inhaled allergen 23 h after dosing in adult asthma: a randomised, controlled trial
by: Oliver Amanda, et al.
Published: (2012-06-01) -
Asthma control using fluticasone propionate/salmeterol in Asian and non-Asian populations: a post hoc analysis of the GOAL study
by: Jean Bousquet, et al.
Published: (2017-04-01)